Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

Retinoids help treat psoriasis effectively, but they can cause side effects and need more research on safe use with other treatments.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

The combination treatment showed a higher response rate but no significant survival benefits.

Belimumab may cause hair loss in lupus patients.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Retinol may affect immune responses in people with frequent skin boils.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

RCS-01 is safe and may help rejuvenate aging skin.

Reticular erythematous mucinosis syndrome can occur with minimal mucin deposition.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Upadacitinib effectively treats pyoderma gangrenosum.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Probiotics may help improve symptoms in rheumatoid arthritis patients.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Deucravacitinib helped a man regrow hair and improve psoriasis.

PRP is effective for treating patchy alopecia areata.